Cytokine mRNA Delivery and Local Immunomodulation in the Placenta using Lipid Nanoparticles

Area of Science:

• Immunology
• Reproductive Biology
• Biotechnology

Background:

• The maternal immune system must balance fetal tolerance with pathogen defense.
• Immune dysregulation at the maternal-fetal interface is linked to pregnancy complications like preeclampsia.
• Preeclamptic placentas show increased inflammation and impaired blood flow, but underlying mechanisms are unclear.

Purpose of the Study:

• To establish lipid nanoparticles (LNPs) as a tool for local immunomodulation within the placenta.
• To investigate the potential of LNP-mediated mRNA delivery for treating pregnancy-related immune dysfunction.

Main Methods:

• Utilized lipid nanoparticles (LNPs) to deliver cytokine-encoding mRNA (IL-4 and IL-13) to placental trophoblasts.
• Assessed cytokine secretion and immune cell polarization in vitro.
• Administered LNPs intravenously to pregnant mice to evaluate placental and systemic immune responses.

Main Results:

• LNP delivery of IL-4 and IL-13 mRNA to trophoblasts induced local cytokine secretion.
• Trophoblast-derived cytokines promoted anti-inflammatory polarization of primary human monocytes.
• A lower mRNA dose correlated with increased alternatively-activated macrophage markers.
• In vivo LNP administration in mice resulted in placental IL-4 and IL-13 secretion with minimal systemic pro-inflammatory cytokine changes.

Conclusions:

• Lipid nanoparticles (LNPs) serve as an effective tool for targeted immunomodulation in the placenta.
• This technology provides a potential therapeutic strategy for immune-related pregnancy complications.
• Further research can explore LNP applications for other inflammatory conditions.